The Nucleic Acid Nanostructures market refers to the industry involved in the design, development, and application of nanostructures composed of nucleic acids, such as DNA and RNA, with relevance to various fields including biotechnology, nanotechnology, and medicine. As the Nucleic Acid Nanostructures market size is anticipated to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant expansion, driven by the increasing demand for innovative diagnostic and therapeutic tools, with the global industry expansion expected to be fueled by advancements in technology and rising investments in research and development, with a compound annual growth rate (CAGR) of 18.2% from 2026 to 2033. The scope of this market encompasses various types of nucleic acid nanostructures, including DNA origami, RNA nanoparticles, and aptamers, with applications in fields such as biomedical research, disease diagnosis, and targeted therapy.